SCYX FY 2017 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$257,000+0.0% YoY

Gross Profit

$257,000100.0% margin

Operating Income

-$26M-10241.2% margin

Net Income

-$25M-9751.0% margin

EPS (Diluted)

$-9.37

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$46M

Total Liabilities

$24M

Stockholders' Equity

$21M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$257,000	$257,000	+0.0%
Gross Profit	$257,000	$257,000	+0.0%
Operating Income	-$26M	-$28M	+5.4%
Net Income	-$25M	-$30M	+16.4%